Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An OPEN LABEL Phase II Safety Study of Bovine Intestinal Alkaline Phosphatase (bIAP), an Inflammation Modulating Moiety, in RA Patients

NCT01416493 is registered in ClinicalTrials.gov with Alloksys Life Sciences B.V. as lead sponsor.

NCT NCT01416493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01416493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An OPEN LABEL Phase II Safety Study of Bovine Intestinal Alkaline Phosphatase (bIAP), an Inflammation Modulating Moiety, in RA Patients
Lead sponsor
Alloksys Life Sciences B.V.
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2011
Completion date
April 30, 2013
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute rheumatoid arthritis